Full Coverage

Cell Genesys Reports Second Quarter 2008 Financial Results (Business Wire)

                   
yahoo.com
Aug 1, 2008
        
Story Timeline:  111 days

Friday August 1, 4:00 pm ET Conference Call Scheduled for 4:30 p.m. ET Today SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cell Genesys, Inc. (Nasdaq:CEGE - News ) today reported financial results for the second quarter ended June 30, 2008. The net loss for the quarter ended June 30, 2008, was $2.8 million ($0.03 per fully diluted share), compared to a net loss of $1.9 million ($0.03 per fully diluted share) for the corresponding period in 2007. The company ended the quarter with approximately $165.5 million in cash, cash equivalents and short-term investments. This includes the $50.0 million payment received from Takeda Pharmaceutical Company Limited in April 2008 pursuant to the collaboration agreement announced on March 31, 2008 for the development and commercialization of GVAX immunotherapy for prostate cancer and gross... [read full story]                    

Add Comment
Latest article on this story:

Cell Genesys Q2 loss widens to $2.8M (at bizjournals.com)

 yahoo.com Aug 3, 2008
First article on this story:

Cell Genesys Reports Second Quarter 2008 Financial Results

 earthtimes.org Aug 1, 2008
Selected publications with coverage of this story:
ibtimes.com canadianbusiness.com yahoo.com bizjournals.com earthtimes.org genengnews.com finanznachrichten.de
RELATED
Found 10 documents:
                   

Cell Genesys Q2 loss widens to $2.8M (at bizjournals.com)

yahoo.com
Aug 3, 2008
        

Silicon Valley / San Jose Business Journal Cell Genesys Inc. on Friday reported a second quarter loss of $2.8 million or 3 cents a share, compared to a loss of $1.9 million or 3 cents a share in the same period last year. South...

Cell Genesys Earnings Call scheduled for 4:30 pm ET today (CCBN)

yahoo.com
Aug 2, 2008
        

Cell Genesys, Inc., a biotechnology company, engages in the development and commercialization of biological therapies for patients with cancer. It develops cell-based cancer immunotherapies and oncolytic virus therapies. The...

                   

Cell Genesys reports wider second-quarter loss despite increased revenue

canadianbusiness.com
Aug 2, 2008
        

SOUTH SAN FRANCISCO, Calif. (AP) - Biotech drug developer Cell Genesys Inc. reported Friday its loss widened in the second quarter, despite a major revenue infusion from a collaboration with Takeda Pharmaceuticals. For the...

                   

Cell Genesys loss widens in the second quarter (AP)

yahoo.com
Aug 2, 2008
        

Friday August 1, 8:26 pm ET Cell Genesys reports wider second-quarter loss despite increased revenue SOUTH SAN FRANCISCO, Calif. (AP) -- Biotech drug developer Cell Genesys Inc. reported Friday its loss widened in the second...

                   

Cell Genesys loss widens in the second quarter

ibtimes.com
Aug 2, 2008
        

SOUTH SAN FRANCISCO, Calif. - Biotech drug developer Cell Genesys Inc. reported Friday its loss widened in the second quarter, despite a major revenue infusion from a collaboration with Takeda Pharmaceuticals. For the period...

                   

Cell Genesys 2Q net loss widens

finanznachrichten.de
Aug 1, 2008
        

SAN FRANCISCO (Thomson Financial) - Cell Genesys Inc. late Friday reported a second-quarter net loss of $2.75 million, or 3 cents a share, versus a year-ago net loss of $1.89 million, or 3 cents a share. Revenue for the quarter...

                   
genengnews.com: Genetic Engineering genengnews.com

Cell Genesys Reports Second Quarter 2008 Financial Results

genengnews.com
Aug 1, 2008
        

News source: Business Wire Cell Genesys, Inc. today reported financial results for the second quarter ended June 30, 2008. This includes the $50.0 million payment received from Takeda Pharmaceutical Company Limited in April...

                   

Cell Genesys Q2 loss widens to $2.8M

bizjournals.com
Aug 1, 2008
        

Silicon Valley / San Jose Business Journal Cell Genesys Inc. on Friday reported a second quarter loss of $2.8 million or 3 cents a share, compared to a loss of $1.9 million or 3 cents a share in the same period last year. South...

                   

Cell Genesys Reports Second Quarter 2008 Financial Results

finanznachrichten.de
Aug 1, 2008
        

Cell Genesys, Inc. (Nasdaq:CEGE) today reported financial results for the second quarter ended June 30, 2008. This includes the $50.0 million payment received from Takeda Pharmaceutical Company Limited in April 2008 pursuant to...

                   
earthtimes.org: SOUTH SAN FRANCISCO, Calif. - Cell Genesys, Inc. (Nasdaq:CEGE) today reported financial results for the second quarter ended June 30, 2008. The net loss for the quarter ended June 30, 2008, was $2.8 million ($0.03 per fully diluted share), compared to a net loss of $1.9 million ($0.03 per fu earthtimes.org

Cell Genesys Reports Second Quarter 2008 Financial Results

earthtimes.org
Aug 1, 2008
        

SOUTH SAN FRANCISCO, Calif. - Cell Genesys, Inc. (Nasdaq:CEGE) today reported financial results for the second quarter ended June 30, 2008. The net loss for the quarter ended June 30, 2008, was $2.8 million ($0.03 per fully...